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ABSTRACT Epidemiologicobservationsthathavebeenmadeinthecontextofthecurrentpandemicinﬂuenzavirusincludeasta-
blevirulencephenotypeandalackofpropensitytoreassortwithseasonalstrains.Inanattempttodeterminewhethereitherof
theseobservationscouldchangeinthefuture,wecoinfecteddifferentiatedhumanairwaycellswithseasonaloseltamivir-
resistantA/NewJersey/15/07andpandemicA/Tennessee/1-560/09(H1N1)virusesinthreeratios(10:90,50:50,and90:10)and
examinedtheresultingprogenyvirusesafter10sequentialpassages.Whenthepandemicviruswasinitiallypresentatmultiplici-
tiesofinfectionequaltoorgreaterthanthosefortheseasonalvirus,onlypandemicvirusgenotypesweredetected.These
adaptedpandemicstrainsdid,however,containtwononsynonymousmutations(hemagglutininK154Qandpolymeraseacidic
proteinL295P)thatconferredamorevirulentphenotype,bothincellculturesandinferrets,thantheirparentalstrains.The
polymeraseacidicproteinmutationincreasedpolymeraseactivityat37°C,andthehemagglutininchangeaffectedbindingofthe
virusto2,6-sialylreceptors.WhentheseasonalA/H1N1viruswasinitiallypresentinexcess,thedominantprogenyviruswasa
reassortantcontainingthehemagglutiningenefromtheseasonalstrainandtheremaininggenesfromthepandemicvirus.Our
studydemonstratesthattheemergenceofanA/H1N1pandemicstrainofhighervirulenceispossibleandthat,despitetheirlack
ofdetectionthusfarinhumans,viableseasonal/pandemicvirusreassortantscanbegenerated.
IMPORTANCE ThisreportsuppliesakeypieceofinformationforinvestigatingfutureevolutionscenariosofpandemicA/H1N1
inﬂuenzainthehumanpopulation.WereportthattheemergenceofanA/H1N1pandemicstrainofhighervirulenceispossible
andthat,despitetheirlackofdetectionthusfarinhumans,viableseasonal/pandemicvirusreassortantscanbegenerated.
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I
nﬂuenza A viruses of the H1N1 subtype have had a signiﬁcant
epidemiologicimpactinhumansbycausingseasonalepidemics
ofvariousdegreesofseverityandtwopandemicsin1918and2009
(1, 2). Despite the recent availability of complete genome se-
quence data, many aspects of the evolutionary and epidemiologic
dynamics of the A/H1N1 virus remain unknown. How different
inﬂuenza subtypes interact with each other and why one subtype
replacesitscounterpartoveraseasonoroverdecadesarecurrently
unclear. Since 2009, two main lineages of A/H1N1 have been cir-
culatinginhumans:thenewswine-originpandemiclineageanda
seasonallineage.SeasonalA/H1N1virusesbecamespontaneously
resistanttotheneuraminidase(NA)inhibitoroseltamivir,thepri-
mary treatment for inﬂuenza virus-infected patients, after the
2007-2008 season and then spread rapidly from Europe around
theglobe(3).Arecentstudyidentiﬁed53areasofcocirculationof
oseltamivir-resistantseasonalandpandemicA/H1N1(4).Despite
limited testing, there are a few reports of mixed infections in
Chinaandinatleast11patientsinNewZealand(4,5).Thislends
supportforthepossibilityofreassortmentbetweenpandemicand
seasonal inﬂuenza viruses, with the likelihood of emergence of an
NA inhibitor-resistant pandemic-like virus if the N1 NA segment
from the oseltamivir-resistant seasonal ancestor were to reassort
with the pandemic strain.
Epidemiologic observations that have been made in the con-
text of the current pandemic inﬂuenza virus include a stable vir-
ulence phenotype and a lack of propensity to reassort with sea-
sonal strains. Indeed, a recent study of A/H1N1 coinfection in
ferretsfoundnoreassortmentandpredictedthedominanceofthe
pandemic virus (6). Additionally, seasonal A/H1N1 strains are
more and more rarely reported worldwide, whereas pandemic
A/H1N1 seems to have almost replaced its seasonal counterpart
(7). Thus, in this study, we made an attempt to determine (i) the
genomic-scaleinteractionbetweenthepandemicandseasonalvi-
ruses, (ii) the pattern of further adaptation of pandemic A/H1N1
inﬂuenzatohumans,and(iii)whethersuchadaptationcouldlead
to substantially increased virulence.
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Coinfection of seasonal and pandemic A/H1N1 inﬂuenza virus
strains in differentiated human cells. We used differentiated
normal human bronchial epithelial (NHBE) cells as a model to
mimicA/H1N1virusevolutioninhumans.NHBEcellswerecoin-
fected with oseltamivir-resistant seasonal A/New Jersey/15/07
(NJ/15) and pandemic A/Tennessee/1-560/09 (TN/560) (H1N1)
virusesindifferentratios(10:90,50:50,and90:10).Thevirusmix-
tures were serially passaged 10
times to provide an opportu-
nity for selection of efﬁciently
adapted genotypes. After three
sequential passages, viruses iso-
lated from all coinfection
groups were plaque puriﬁed in
Madin-Darby canine kidney
(MDCK) cells, and 25 clones
pergroupweregenotypedtoes-
tablish the origin of each of the
eight genes that constitute the
inﬂuenza virus (Fig. 1) (8, 9).
The method was not quantita-
tive and was used as a rough es-
timate of virus genes present.
Among all the samples ana-
lyzed, TN/560 dominated over
NJ/15, although dual genotypes
(plaques containing the same
genes of both parental viruses)
were still present for all genes
andinallthreegroups.Notably,
virusescarryingtheNJ/15hem-
agglutinin (HA) gene were iso-
lated at higher frequencies (39
to 50%) from NHBE cultures
that were initially coinfected
with a proportion of seasonal
A/H1N1equaltoorhigherthan
that of the pandemic virus
(Fig. 1B and C).
We assayed whether pan-
demic/seasonal reassortants
could be favored by analyzing
viral genomes (n  30) after 10
passages in NHBE cells (Ta-
ble1).Auniquereassortantcar-
rying NJ/15 HA in a TN/560
backbone was systemically se-
lected (92%) in the group with
an initial predominance of NJ/
15. In the two other coinfection
groups, all recovered viruses
possessed all eight genes from
the pandemic TN/560 virus
(Table 1). The proportions of
HA and NA RNAs of each virus
after each passage in coinfected
NHBE cells were quantiﬁed by
multiplex real-time reverse
transcriptase PCR (RT-PCR)
(seeFig.S1inthesupplementalmaterial).BothHAandNARNAs
ofTN/560dominatedearlyinthegroups,withinitialproportions
of the pandemic virus that were equal to or higher than those of
the seasonal virus (Fig. S1A and B). Evidence of reassortment be-
tween seasonal and pandemic strains was conﬁrmed for the 90:10
NJ/15-TN/560 coinfection group starting from passage 1
(Fig. S1C). Taken together, our ﬁndings showed that pandemic
A/H1N1 dominated over its seasonal counterpart in the NHBE
FIG 1 Genotypes of virus populations recovered after three sequential passages in cultures of differentiated
normal human bronchial epithelial (NHBE) cells coinfected with 10% NJ/15-90% TN/560 (A), 50% NJ/15-50%
TN/560(B),and90%NJ/15-10%TN/560(C)mixturesofseasonalandpandemicH1N1inﬂuenzaviruses.Results
are shown for genotypes of NJ/15 or TN/560 or dual genotypes of plaque-puriﬁed viruses (n  25).
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twoA/H1N1viruseswasalsoobserved,butonlyinthegroupwith
an initial dominance of the seasonal strain. The fact that such
reassortant viruses acquired the HA gene from the seasonal
A/H1N1 virus suggests that the pandemic HA gene segment may
not yet be optimal for viral replication in humans.
Tomonitortheemergenceofadaptiveaminoacidchanges,the
complete genomes of six clones isolated from each group were
sequenced. HA K154Q (H1 numbering) and/or polymerase acid
(PA) protein L295P mutations were observed in two groups with
an initial 50% or 90% proportion of TN/560 (Table 1). A poly-
merase basic 2 (PB2) protein D87N mutation was observed in all
theclonesrecoveredfromthegroupwithaninitialpredominance
of NJ/15. The two A/H1N1 strains that represented two major
genotypes isolated from coinfected NHBE cells were designated
G1 (TN/560-like virus with PA L295P and HA K154Q) and G2
(reassortant NJ/15 HA in a TN/560 backbone with PB2 D87N)
and were further analyzed (Table 1).
Replication and pathogenicity of G1 and G2 viruses in cell
culture and in ferrets. We ﬁrst studied the growth of G1 and G2
viruses both in eggs and in MDCK cells (see Table S1 in the sup-
plementalmaterial).Theyieldsofbothvirusesincellculturewere
signiﬁcantly higher (~1.5 logs) than those of their parental TN/
560 and NJ/15 strains (P  0.01). G1 and G2 formed larger
plaques (diameter, 1.5 to 2.2 mm) than the parental counterparts
(diameter, 0.6 to 1.1 mm) (Table S1). To assess the relative repli-
cation efﬁciencies of the G1 and G2 viruses, the multiple-cycle
replication kinetics of these viruses in comparison with the levels
forTN/560andNJ/15inNHBEcellswereexamined.Thereplica-
tion levels of G1 and G2 were signiﬁcantly higher than those of
both parents 24, 48, and 72 h after infection at 37°C (0.9 to 1.8
logs; P  0.05) (Fig. 2A). Higher titers of G1 and G2 than of
TN/560werealsoobserved48and72hoursafterinfectionat33°C
(0.6 to 1.3 logs; P  0.05) (Fig. 2B).
To determine whether the G1 and G2 variants acquired in-
creasedvirulenceinvivo,wefurthercharacterizedthepathogenic-
ity and transmissibility potentials of A/H1N1 viruses in ferrets.
Fourgroupsoftwoferrets(Mustelaputoriusfuro)eachwereinoc-
ulatedwith106PFUofTN/560,NJ/15,G1,orG2(Table2;seealso
Fig.S2inthesupplementalmaterial).After24h,twonaïveferrets
(contacts) were housed in the same cage with two inoculated fer-
rets (donors) to assess direct-contact transmission. All A/H1N1
viruses caused only mild clinical signs (relative inactivity index
[RII], 0.1), without marked weight changes (~4 to 10%) (Ta-
ble 2). The body temperature elevation was slightly higher in an-
imals inoculated with G1 and G2 than in those inoculated with
parental viruses (mean peak increases of 1.6°C and 0.4°C for do-
nors and contacts, respectively). The donor ferrets inoculated
with G1 had signiﬁcantly higher nasal wash titers on day 1 post-
inoculation (p.i.) than the TN/560-infected animals had (P 
0.01).Thedurationofinfectious-virussheddingwas2dayslonger
for animals inoculated with G1 or G2 viruses than for animals
inoculated with either TN/560 or NJ/15 (Fig. S2A). Although all
four A/H1N1 strains transmitted efﬁciently, as shown by virus
shedding as well as by seroconversion (Table 2), G1 and G2 con-
tact ferrets exhibited signiﬁcantly higher virus titers in the upper
respiratorytractthantheTN/560grouponalldaysstudied(1.5
to 3.8 logs; P  0.01) (Fig. S2A). Comparison of the protein con-
centrations and total cell counts in the nasal washes showed a
statisticallysigniﬁcantdifferencebetweenG2andallotherviruses
on day 2 p.i. (P  0.01), suggesting an increased inﬂammation in
the upper respiratory tract (Fig. S2D and E).
To evaluate virus replication and tissue tropism of A/H1N1
viruses in ferrets, we determined virus titers in the lungs, nasal
turbinate, trachea, spleen, liver, and small intestine of one inocu-
latedferretpergrouponday3p.i.(Fig.2C).Whilenoevidenceof
infectious virus was found in the liver or spleen tissues of any
animalstested,allfourvirusesweredetectedinthelungsandnasal
turbinates.Consistentwiththemore-pronouncedclinicalsignsof
disease,G1exhibitedthewidesttissuetropismandwasdetectedat
highertitersinthreeoutoffourlobesofthelungs(~6.8log1050%
tissue culture infective doses [TCID50]/gram tissue) and small in-
testine (~3.4 log10 TCID50/gram tissue) (Fig. 2C). Histopatho-
logic analysis revealed that the lungs of donor ferrets inoculated
with G1 had signiﬁcantly more necrotizing bronchiolitis and al-
veolitisthanthelungsfromanimalsinfectedwithTN/560,NJ/15,
or G2, which exhibited infection restricted either to the bronchi-
oles or to the alveolar interstitium (Fig. 2D). Taken together, our
ﬁndings showed that two variants selected by coinfection of hu-
mancellsacquiredincreasedreplicativeﬁtnessandvirulenceboth
in vitro and in vivo.
Effect of observed mutations on viral polymerase activity,
receptor speciﬁcity, and antigenicity. A luciferase minigenome
assaywasusedtostudytheroleofribonucleoprotein(RNP)com-
plex mutations in the viral replication, comparing G1 and G2 to
TN/560. The G1 RNP complex, carrying the PA L295P mutation,
showed ~20% more polymerase activity than TN/560 at 37°C
(and comparable activities at 33°C and 39°C) (Fig. 3A). The G2
TABLE 1 H1N1 reassortant genotypes recovered after 10 sequential passages from differentiated NHBE cultures coinfected with seasonal NJ/15
and pandemic TN/560 (H1N1) inﬂuenza viruses
Coinfection group
Genotypea
No. of
isolates with
the described
genotype/total
no. of viruses
examined Abbreviation
Molecular
change(s)
during
coinfectionb PB2 PB1 PA HA NP NA M NS
10% NJ/15-90% TN/560 TN TN TN TN TN TN TN TN 30/30 G1 PA L295P; HA K154Q
50% NJ/15-50% TN/560 TN TN TN TN TN TN TN TN 31/31 PA L295P
90% NJ/15-10% TN/560 TN TN TN NJ TN TN TN TN 24/26c G2 PB2 D87N
a NJ, gene derived from the NJ/15 parental virus; TN, gene derived from the TN/560 parental virus.
b Molecular changes are shown based on the sequences of the ~20 to 25% of plaque-puriﬁed viruses isolated from NHBE culture supernatants from three coinfection groups (H1
HA numbering) (20).
c 2 H1N1 clones had a mixed NJ/TN genotype for the HA gene.
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33°C (30%) but a slightly lower one at 39°C (10%) than TN/
560RNP(P0.05)(Fig.3A).Interestingly,growthcurvesat33°C
showedthatbothG1andG2grewfasterthanTN/560atlatertime
points (Fig. 2B), suggesting an advantage for the adapted viruses
forreplicationintheupperrespiratorytract.Atleastinthecaseof
G2,itappearsthatthePB2D87Nmutationmayplayaroleinviral
replication and that this mutation functions by increasing poly-
merase activity. The discrepancy between comparative growth
curve and polymerase assay data at 33°C for G1, however, clearly
shows that polymerase activity is not the sole reason for increased
viral production from human
airway cells, at least at this tem-
perature.
The receptor speciﬁcities of
all four A/H1N1 viruses were
also compared (Fig. 3B) (9).
The patterns of binding to fe-
tuin were identical among all
isolates (association constant
[Kass], 6.9  1.4; 1/M sialic
acid)andnegligibletothe“avian-
type” 3=-sialylglycopolymer (3=-
SL). NJ/15 and G2 viruses
showed signiﬁcantly less bind-
ing to both “human-type” 6=-
sialylglycopolymer (6=-SL) and
6=-sialyllactosamine(6=-SLN)re-
ceptors than did the pandemic
TN/560 strain (~3-fold differ-
ence;P0.05)(Fig.3B).Incon-
trast,theG1variant(withtheHA
K154Q substitution) exhibited
an afﬁnity for the 6=-SLN sialic
polymer similar to that observed
for TN/560 but was unable to
bind to 6=-SL, indicating that G1
discriminated both 2,6-linked
receptors (Fig. 3B). Given the
preferential binding of human
H1N1 viruses to a 6=-SLN recep-
tor(10),ourﬁndingssuggestthat
the HA K154Q mutation is a
mammal-associated change that
leads to better reﬁnement of
receptor-binding properties of
currently circulating pandemic
A/H1N1 viruses.
To test whether the acquired
HA K154Q mutation changed
the antigenic speciﬁcity of the
pandemic TN/560 virus, we de-
terminedtheantigenicproperties
of all A/H1N1 viruses in a hem-
agglutinationinhibition(HI)test
using postinfection ferret anti-
sera and monoclonal antibodies
(MAbs) raised against a selection
of currently circulating seasonal,
pandemic, and swine H1 isolates
(see Table S2 in the supplemental material). TN/560 and G1 did not
react with the ferret postinfection antisera or MAbs raised against
contemporaryhumanorswineH1viruses,whichwasingoodagree-
ment with earlier ﬁndings (11). G1 exhibited a slight change in reac-
tivity with H5, E2, and H7 MAbs (Table S2), suggesting that the HA
mutation at residue 154 may play a role in antigenicity.
DISCUSSION
Inourstudy,coinfectionofhumanairwaycellswithtwoA/H1N1
strains allowed us to study the possible interactions between vi-
ruses, which are difﬁcult to assess on the basis of surveillance data
FIG 2 Replication of NJ/15, TN/560, and two recovered H1N1 genotypes, G1 and G2, in NHBE cells and ferrets.
(AandB)NHBEcultureswereinfectedviatheapicalsidewitheachvirusatanMOIof0.1ateither37°C(A)or33°C
(B). The progeny viruses released from the apical surfaces of infected cultures were collected at the indicated time
pointsandtitratedinMDCKcellsbyperformingaplaqueassay.Representativeresultsexpressedaslog10numbers
of PFU/ml from three independent experiments are shown. *, P  0.05; °, P 0.01 compared with the value for
TN/560 virus (one-way ANOVA). (C) Four ferrets were intranasally inoculated with 106 PFU of each virus, and
3dayslater,tissueswerecollectedandvirustitersweredetermined.Virustitersareexpressedaslog10TCID50/gram
tissue for one ferret. (D) The images shown are hematoxylin-and-eosin-stained sections of lung tissue from donor
ferrets inoculated with TN/560, G1, or G2 (H1N1) inﬂuenza viruses obtained on day 3 postinoculation. The
TN/560 lung infection was primary restricted to the bronchioles and consisted of epithelial necrosis and regener-
ationassociatedwithintraluminalsloughedepithelialcellsandmononuclearinﬂammatorycells.TheG1infection
involved the bronchioles and alveoli and consisted of bronchiolar epithelial necrosis and regeneration associated
with alveolar pneumocytes hyperplasia and mononuclear inﬂammatory cell inﬁltrates. The pathologic changes in
the G2-infected lungs were restricted to the alveolar interstitium only. The alveolar spaces were free of inﬂamma-
tory cells, whereas the alveolar interstitial walls were hypercellular with mononuclear cells. Magniﬁcation, 20.
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mune system, which would obviously play a role in virus adapta-
tion, it is worth mentioning that our model correlated well with
whathasbeenseeninnature.Therefore,thisworkcouldbeuseful
inidentifyingnewpossibleA/H1N1inﬂuenzavirusevolutionsce-
narios.Ourﬁndingssuggestthatgenerationofviableintrasubtype
reassortment between currently circulating oseltamivir-resistant
seasonal and pandemic viruses is possible but requires initial
dominance of the seasonal A/H1N1 strain. Although we did not
observetheemergenceofadrug-resistantreassortant,theG2vari-
ant was more ﬁt than its parental strains for replication in ferrets.
The lack of detection of such reassortants before now may be
explained by a too-low ratio of seasonal to pandemic A/H1N1
strains.
We anticipate that the more favorable adaptation scenario for
the A/H1N1 pandemic virus seems to tend toward an antigenic
drift than a shift. Indeed, in two out of three coinfection groups
studied,thepandemicgenotypedominated.Ourdatashowedthat
the acquisition of two nonsynonymous mutations in the HA
(K154Q) and PA (L295P) genes resulted in rapid selection of the
pandemicviruswithimprovedreplicationandvirulence.Allpan-
demic A/H1N1 viruses except TN/560 possessed a proline at res-
idue295inthePAprotein,indicatingaselectiveadvantageforthis
mutationinthemammalianhost,suchasbetterreplicationinthe
upperrespiratorytract,asconﬁrmedbyminigenomedata.Incon-
trast,theHAK154QsubstitutionidentiﬁedinG1wasnotpresent
in any contemporary pandemic A/H1N1 inﬂuenza virus exam-
ined. Located next to the HA receptor-binding site, the K154Q
mutation affected the protein structure such that binding to the
6=-SL receptor became impossible, probably because of an in-
crease of the negative charge of the HA molecule. Thus, this HA
mutation, resulting in a typical human virus-like preference due
to strong recognition of only 6=-SLN sialosides, could contribute
to the increased initial ability of the virus to infect and spread in
the human airway and lung epithelium. In addition, it was deter-
minedpreviouslythatadaptationofthePB2proteinisalsocrucial
for efﬁcient transmission of A/H1N1 inﬂuenza virus (12). In this
study,asinglemutation,PB2D87N,wasresponsibleforincreased
G2 RNP polymerase activity at the lower temperature (33°C)
foundinthemammalianairwayand,therefore,probablycontrib-
utedtobetterreplicationinthenose,signiﬁcantlyelevatedinﬂam-
mation, or more efﬁcient transmission. It is noteworthy that
alignmentoffullPB2proteinsshowedtheD87Nmutationonlyin
0.06% of sequenced isolates. We believe that surveillance should
involve careful examination of the adaptive changes identiﬁed
hereaspossiblemarkersforenhancedmorbidityofthepandemic
viruses.Inconclusion,ourstudydemonstratesthattheemergence
of a more virulent A/H1N1 pandemic strain is possible.
MATERIALS AND METHODS
Celllinesandviruses.MDCKandhumanembryonickidney(293T)cells
were obtained from the American Type Culture Collection. NHBE cells
were obtained from Cambrex Bio Science. All cell cultures were main-
tained as previously described (13, 14). For NHBE cell differentiation,
culturemediumwaskeptonboththebasalandtheapicalsidesofthecells
for 10 to 14 days, until the cells formed a monolayer. The cells were then
left at an air-liquid interface (with medium on the basal side only) for
another 2 to 3 weeks so that they could differentiate into polarized cul-
tures.
The seasonal NJ/15 and pandemic TN/560 (H1N1) inﬂuenza viruses
wereobtainedfromtheWorldHealthOrganizationcollaboratinglabora-
tories. Stock viruses were prepared in MDCK cells at 37°C for 72 h, and
aliquots were stored at –70°C until used.
CoinfectionstudieswithNHBEcells.DuplicatedifferentiatedNHBE
cell cultures were washed extensively with sterile phosphate-buffered sa-
line (PBS) and then were inoculated via the apical side with mixtures of
seasonalNJ/15andpandemicTN/560viruspairsatdifferentratios(10:90,
50:50, and 90:10). NHBE cells were inoculated with mixtures of the two
viruses at a multiplicity of infection (MOI) of 0.1 in 100 l of inoculum.
After1ho fincubation, the inoculum was removed, and the cells were
thenincubatedat37°Cfor72h.Virusesreleasedintotheapicalcompart-
ment of NHBE cells were harvested by the apical addition and collection
of300lofmediumallowedtoequilibratefor30min.Then,100lofthe
sample was used as an inoculum for the next passage.
Genotyping.Todetermineifreassortantvirusesemergedintheapical
medium samples of coinfected NHBE cultures, a genotyping analysis of
plaque-puriﬁed viruses isolated from the harvested samples was per-
formedafteratotalof3(n25)or10(n30)passages.Aftercompletion
TABLE 2 Replication and transmission of NJ/15, TN/560, G1, and G2 (H1N1) inﬂuenza viruses in ferrets
Virus
Animal
group
Clinical signs Virus detection
Seroconversion values
(serum HI titer/neutralizing titer)d
Wt
loss
(%)a
Increase
in temp
(°C)
(day of onset)
Peak virus titer
(log10 TCID50/ml)
(day of onset)b
Last day of
sheddingc NJ/15 TN/560 G1 G2
NJ/15 Donors 10.5 1.2 (2) 5.6e (2) 6 160/40 / / 160/40
Contacts 4.5 0.9 (1) 5.4 (3) 9 160/20 / / 240/40
TN/560 Donors 8.9 1.0 (1) 6.7 (2) 6 / 320/120 320/1,280 /
Contacts 2.0 0.6 (3) 5.2 (3) 7 / 320/240 320/640 /
G1 Donors 9.1 2.5 (2) 7.2 (2) 8 / 160/20 640/2,560 /
Contacts 2.2 1.3 (3) 7.4° (3) 9 / 160/60 940/1,280 /
G2 Donors 4.1 2.8 (2) 6.1 (2) 8 320/80 / / 320/40
Contacts 2.5 1.0 (4) 6.7 (3) 9 640/200 / / 640/180
a The maximum percent weight loss during the 21 days p.i.
b Virus titer in nasal washes.
c The ﬁrst day of observation on which virus was not detected.
d Hemagglutination inhibition (HI) antibody titers in ferret sera were determined at 21 days p.i.; values are expressed as reciprocals of serum that inhibited 4 hemagglutination
units of H1N1 inﬂuenza virus. Neutralizing antibodies to H1N1 viruses (100 TCID50) were titrated in MDCK cells. Data (arithmetic mean titers) are shown for 1 ferret (for donors)
or groups of 2 ferrets (for contacts). Homologous HI/neutralizing titers are shown in bold type. , titer of 1:10.
e P  0.01 compared with the nasal wash virus titer for TN/560 virus (donors compared with donors and contacts with contacts; one-way ANOVA).
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notypes were subsequently cloned twice by plaque puriﬁcation in MDCK
cells, and the cloned viruses were passaged once in the MDCK cells for
72 h at 37°C to prepare a virus stock.
One-step reverse transcriptase PCR (RT-PCR; Qiagen) was also used
to determine the NJ/15- or TN/560-based origin of each gene in plaque-
puriﬁed virus populations after a total of 3 (n  25) or 10 (n  30)
passages in coinfected NHBE cells. Primers were designed to hybridize
speciﬁcally to each NJ/15- or TN/560-derived gene segment at appropri-
ateannealingtemperatures(8).MultiplexreactionsusingNJ/15-andTN/
560-speciﬁcprimersforeachviralgenewereperformedtosimultaneously
detectbothNJ/15-andTN/560-derivedgenesofdifferentampliconsizes.
Real-time RT-PCR. Copy numbers of HA and NA RNAs of NJ/15
and TN/560 viruses were quantiﬁed by multiplex quantitative real-
time RT-PCR using primers and probes speciﬁc for NJ/15 and TN/560
RNAs (HA-Fwd [5= CCATTGCCGGTTTCATTG 3=] and HA-Rev
[5= AATGGCATTYTGTGTGC 3=] for H1 HA of both NJ/15 and
TN/560 viruses; NJ-HA-PRO [5= VIC–GCCAGATCCTTGCTCATTC–6-
carboxytetramethylrhodamine {TAMRA} 3=] and TN-HA-PRO [5= 6-
carboxyﬂuorescein {FAM}–GGACAGGGATGGTAGATGGA–TAMRA 3=]
for H1 HA of NJ/15 and TN/560, respectively; NA-Fwd [5= AGTGGAT-
GGGCTATATACA 3=] and NA-Rev [5= CCATTKGAATGTTTGT-
CATTTA 3=] for N1 NA of both NJ/15 and TN/560; and NJ-NA-PRO
[5= VIC-AAGAATTGGCTCCAAAGGA-TAMRA 3=] and TN-NA-PRO
[5=FAM-GGAATGCAGAACCTTCTTCT-TAMRA 3=] for N1 NA of NJ/15
andTN/560,respectively).Real-timeRT-PCRwasperformedusingaQiagen
one-step RT-PCR kit, 600 nmol/liter of each primer, 500 nmol/liter of the
TN/560-speciﬁcprobe,100nmol/literoftheNJ/15-speciﬁcprobe,and2mM
MgCl2(Roche). Quantitative real-time RT-PCR was done using an ABI Fast
real-time PCR system 7500 thermocycler and corresponding software
(Stratagene), with the following cycling conditions: 50°C for 30 minutes and
95°Cfor15minutes,followedby40cyclesof94°Cfor20s,58°Cfor30s,and
72°C for 40 s. RNA standards were quantiﬁed using a NanoDrop 1000 spec-
trophotometer (Thermo Scientiﬁc), and real-time RT-PCR efﬁciencies were
similar for HA and NA RNA of NJ/15 and TN/560H1N1 viruses, ranging
from 2.5 to 2.7.
Virus sequence analysis. Viral RNAs (vRNAs) were isolated from
virus-containing cell culture ﬂuid by using an RNeasy minikit (Qiagen).
Samples were reverse transcribed and analyzed by PCR using universal
primers, as described previously (15). Sequencing was performed by the
Hartwell Center for Bioinformatics and Biotechnology at St. Jude Chil-
dren’s Research Hospital and edited by using the Lasergene sequence
analysis software package (DNASTAR).
Infectivity and replication kinetics of A/H1N1 inﬂuenza viruses.
The infectivity of A/H1N1 viruses was determined by 50% tissue culture
infectivedose(TCID50),PFUcount,and50%egginfectiousdose(EID50)
as described previously (13, 16).
To determine multistep growth curves for NHBE cells, triplicate cell
cultures growing in 12-mm-diameter inserts were inoculated via the api-
cal side with each virus at an MOI of 0.1 at 33°C or 37°C. After1ho f
incubation, the inoculum was removed. Viruses released into the apical
compartment of NHBE cells were harvested at the indicated time points
by the apical addition and collection of 300 l of medium allowed to
equilibratefor30minat33°Cor37°C.Thevirustitersweredeterminedas
log10 numbers of PFU/ml in MDCK cells.
Assessment of virus pathogenicity and transmission in ferrets.
Pathogenicity in 4- to 5-month-old male ferrets obtained from Marshall
Farms (North Rose, NY) was tested. All ferrets were seronegative for in-
ﬂuenza A H1N1, H3N2, and H5N1 and for inﬂuenza B viruses. Donor
ferrets were initially housed separately from contact ferrets. The donor
ferrets (two for each group) were inoculated intranasally under light
isoﬂurane anesthesia with 106 PFU of NJ/15, TN/560, G1, or G2 virus in
1 ml of sterile PBS. For the direct-contact transmission experiment, 24 h
after inoculation (day 1 postinoculation [p.i.] for the inoculated ferrets
and day 0 postcontact [p.c.] for the contact ferrets), two naïve direct-
contact ferrets were housed in the cage with two donor ferrets. Clinical
signs of infection, relative inactivity index (17), weight, and temperature
were recorded daily.
To monitor virus shedding, nasal washes were collected from ferrets
ondays1,2,4,6,8,and10p.i.(ordays1,3,5,7,and9p.c.).Thevirustiters
were determined as log10 TCID50/ml in MDCK cells. The limit of virus
detection was 0.5 log10 TCID50/ml. For calculation of the mean, samples
with virus titers of 0.5 log10 TCID50/ml were assigned a value of 0.
Inﬂammatorycellcountsandproteinconcentrationsinnasalwasheswere
also determined.
Todetermineinﬂammatory-cellcounts,thenasalwasheswerecentri-
fugedat2,000rpmfor10min.ThecellpelletwasresuspendedinPBS,and
FIG3 PolymeraseactivityandreceptorspeciﬁcityofH1N1inﬂuenzaviruses.(A)
Polymerase activity of ribonucleoprotein complexes of TN/560, G1, and G2
(H1N1)virusesasdeterminedbyadual-luciferasereporterassayinthreeindepen-
dent experiments. 293T cells were transfected in triplicate with luciferase and
Renilla reporter plasmids, together with plasmids expressing PB2, PB1, PA, and
NP from either TN/560, G1, or G2 viruses. Cells were incubated at 33°C (orange
bars),37°C(redbars),or39°C(purplebars)for24h,andcelllysateswereanalyzed
tomeasureﬁreﬂyluciferaseandRenillaactivities.Thelatterwasusedtonormalize
transfection efﬁciency. Values shown represent the activities of each ribonucleo-
protein (RNP) complex relative to that of TN/560. *, P  0.05; °, P 0.01 com-
paredwiththevalueforTN/560virus(one-wayANOVA).(B)Receptorspeciﬁcity
of NJ/15, TN/560, G1, and G2 (H1N1) inﬂuenza viruses. Association constants
(Kass) of virus complexes with “human-type” sialylglycopolymers conjugated to
6=-SLand6=-SLNareshown.HigherKassvaluesindicatestrongerbinding.Values
are the means from four independent experiments. *, P  0.05; °, P 0.01 com-
pared with the value for TN/560 virus (one-way ANOVA).
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counter (Invitrogen). The total number of inﬂammatory cells was calcu-
latedonthebasisoftheinitialvolumeofnasalwash.Theproteinconcen-
tration in cell-free nasal washes was measured by using Bio-Rad protein
assay dye reagent (Hercules).
All animal experiments with H1N1 inﬂuenza A viruses were per-
formed in biosafety level 2 facilities at St. Jude Children’s Research
Hospital(Memphis,TN).AllanimalstudieswereapprovedbytheSt.Jude
Children’s Research Hospital Animal Care and Use Committee and were
conducted according to applicable laws and guidelines.
Titrationofvirusinferretorgans.Onedonoranimalinoculatedwith
NJ/15, TN/560, G1, or G2 virus was euthanized by intracardiac injection
of euthanasia V solution on day 3 p.i., and tissue samples (~0.5 g each)
were collected from lungs (4 lobes tested separately), nasal turbinates,
tracheae, spleens, livers, and small intestines. Samples were homogenized
in 1 ml of sterile PBS with antibiotics, and the virus titer (log10 TCID50/
gram tissue) in MDCK cells was determined.
Histopathologic analysis. Tissues (lung, nasal turbinate, trachea,
spleen, liver, and small intestine) of donor ferrets were collected at the
time of necropsy, ﬁxed in 10% neutral buffered formalin, and embedded
in parafﬁn. Sections 5 m thick were stained with hematoxylin and eosin
and studied by light microscopy.
Serologic tests. Serum samples were collected from ferrets 3 weeks
after inoculation, treated with receptor-destroying enzyme, heat inacti-
vatedat56°Cfor30minutes,andtestedbyahemagglutinationinhibition
(HI) assay with 0.5% packed turkey red blood cells by a standard method
as described previously in the World Health Organization manual on
animalinﬂuenzadiagnosisandsurveillance(18).Virus-neutralizingtiters
were determined by infection of MDCK cells and expressed as the recip-
rocalofthehighestserumdilutionthatneutralized50%of100TCID50of
virus after incubation at 37°C for 72 h.
Minigenome assay for polymerase activity. Subconﬂuent monolay-
ers of 293T cells (7.5  105 cells in 35-mm dishes) were transfected with
the luciferase reporter plasmid (enhanced green ﬂuorescent protein
[EGFP] open reading frame in pHW72-EGFP replaced with the ﬁreﬂy
luciferase gene) (19) and a mix of PB2, PB1, PA, and NP plasmids (TN/
560ormutated)inquantitiesof1,1,1,and2g,respectively.Theplasmid
pGL4.75[hRluc/CMV] vector, which expresses Renilla luciferase (Pro-
mega), was used as an internal control for the dual-luciferase assay. As a
negativecontrol,293Tcellsweretransfectedwiththesameplasmids,with
the exception of the NP expression plasmid. After 24 h of incubation at
33°C, 37°C, or 39°C, cell extracts were harvested and lysed, and luciferase
levelswereassayedwiththedual-luciferaseassaysystem(Promega)anda
BD Monolight 3010 luminometer (BD Biosciences). Experiments were
performed in triplicate.
Receptor-binding assay. The binding of H1N1 inﬂuenza viruses to
fetuin (containing 2,3- and 2,6-linked sialyl receptors) was measured
in a direct solid-phase assay using the immobilized virus and horseradish
peroxidase-conjugated fetuin, as described previously (9). The afﬁnity of
viruses for synthetic 3=- and 6=-sialylglycopolymers obtained by conjuga-
tion of a 1-N-glycyl derivative of 3=-o r6 =-sialyllactose (3=-SL or 6=-SL,
respectively)or3-aminopropylglycosideof6=-sialyllactosamine(6=-SLN)
with poly(4-nitrophenylacrylate) was measured in a competitive assay
based on the inhibition of binding to peroxidase-labeled fetuin (9). Asso-
ciation constant (Kass) values were determined as the sialic acid (N-
acetylneuraminic acid [Neu5Ac]) concentration at the point represented
by maximum binding site value (Amax)/2 on Scatchard plots.
Statistical analysis. The virus yields, plaque sizes, virus titers in nasal
wash samples, and differences in fevers, weights, total numbers of cells,
and protein concentrations in nasal wash samples observed for ferrets
inoculated with H1N1 viruses were compared by analysis of variance
(ANOVA). A probability value of 0.05 was prospectively chosen to indi-
cate that the ﬁndings were not the result of chance alone.
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